Tinactin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tinactin
Generic name: TOLNAFTATE
Manufacturer: Bayer HealthCare LLC.
Product type: HUMAN OTC DRUG
SPL set ID: 0a80a5b0-3216-46f6-8801-7066ef59aee4
SPL ID: 4526d753-799d-0ec3-e063-6294a90a270f
Version: 13
Effective date: 2025-12-04
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:46:06

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Tinactin	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		Bayer HealthCare LLC.	openfda.manufacturer_name
ndc	package	11523-0934-2	openfda.package_ndc
ndc	product	11523-0934	openfda.product_ndc
ndc11	package	11523093402	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
rxcui		209651	openfda.rxcui
spl id		4526d753-799d-0ec3-e063-6294a90a270f	id
spl set id		0a80a5b0-3216-46f6-8801-7066ef59aee4	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on children under 2 years of age except under the advice and supervision of a doctor. When using this product avoid contact with the eyes Stop use and ask a doctor if irritation occurs there is no improvement within 2 weeks Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.